LOS ANGELES (MarketWatch) — Drug makers face another patent cliff in which the industry will lose roughly $65 billion in revenue through the end of 2019, according to a research firm’s report. But the 376-page study from London-based GlobalData says this cliff will be more…
Read More
Latest in Nexium Archives - Access International Patent